Skip to main content

zw171

zw171: 1 clinical trial tracked.

zw171 evidence translation

What we can confirm

1 tracked trial

No verified listed company relationship

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about zw171, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

Clinical Trial Registry Records (1)

A Phase 1, Open-label, Multicenter Study of ZW171 in Participants With Advanced or Metastatic Ovarian Cancer, Non-small Cell Lung Cancer (NSCLC), and Other Mesothelin Expressing Cancers

NCT06523803Registry updated 2025-10-21·Phase 1
Terminated

Primary endpoint: Incidence of dose-limiting toxicities (DLTs; Part 1)

Interventionalopen32 enrolledStarted 2024-09Completion 2025-1015 sites · Germany, South Korea, United Kingdom, United StatesZymeworks BC Inc.